New evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of ...
A new study from researchers at Baylor College of Medicine brings hope for a more personalized approach to treat estrogen receptor-positive (ER+) breast cancer, the most common type of this cancer.
SurvivorNet on MSN
Three things you should know about the ESR1 mutation in breast cancer
One of the most important developments in breast cancer, especially for people with hormone receptor-positive (HR+) advanced ...
About 95% of women reported symptom relief following this treatment THURSDAY, Nov. 20, 2025 (HealthDay News) — Plasma infusions may help breast cancer survivors avoid genital and urinary symptoms ...
A new study from researchers at Baylor College of Medicine brings hope for a more personalized approach to treat estrogen receptor-positive (ER+) breast cancer, the most common type of this cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results